Pharmacovigilance and Drug Safety Software Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Pharmacovigilance and Drug Safety Software
Market Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Pharmacovigilance and Drug Safety Software
Market Research Report The latest report by
IMARC, titled Pharmacovigilance and Drug Safety
Software Market Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028
finds that the global pharmacovigilance and drug
safety software market reached a value of US
189.9 Million in 2022. Pharmacovigilance (PV)
and drug safety software is a management solution
that enables the creation, classification,
review, submission, and maintenance of PV data
and adverse event reports. The process involves
monitoring medical drug effects to identify and
examine the unfavorable reactions of the drugs.
It creates more knowledge and awareness among
healthcare professionals. PV and drug safety
software offers swift science-based safety
decisions, ensures global regulatory compliance,
integrates safety and risk management, and lowers
the cost of PV procedures. As a result, the
software is extensively employed by pharma and
biotech companies, contract research
organizations (CROs), business process
outsourcing firms (BPOs), and other PV service
providers. Request Free Sample Report
https//www.imarcgroup.com/pharmacovigilance-drug-
safety-software-market/requestsample
4
Report Description and Highlights
Report Description

Global Pharmacovigilance and Drug Safety Software
Market Trends The market is primarily driven by
the growing adoption of PV and drug safety
software by various clinical research and
outsourcing companies. The rising prevalence of
chronic diseases, coupled with the increasing
incidence rates of adverse drug reactions (ADRs),
are also fueling the growth of the market. In
addition to this, the easy adoption of the
software due to the availability of cutting-edge
technology is also propelling the market growth.
Governments across various countries are imposing
strict regulations for the commercialization of
drugs. Consequently, the growing complexity
related to drug safety regulations is also
propelling the market growth. Furthermore, rapid
digitization of clinical trials, along with the
adoption of advanced technologies that improve
compliance and product safety in PV and drug
safety software, is creating a positive outlook
for the market. Looking forward, the market is
expected to reach a value of US 283.3 Million by
2028, exhibiting a CAGR of 6.51 during the
forecast period (2023-2028). Looking forward,
the market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Functionality
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
Breakup by Delivery Mode On-premises
Cloud-based Breakup by End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Business Process Outsourcing Firms
Others Breakup by Region

6
Report Description and Highlights
Report Description
North America United S
tates Canada Asia-Paci
fic China Japa
n India South
Korea Australia
Indonesia Others Eur
ope Germany Fr
ance United Kingdom
Italy Spain
Russia Others Lati
n America

7
Report Description and Highlights
Report Description
Brazil Mexico
Others Middle East and
Africa


8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Ab Cube
• Anju Software Inc. ArisGlobal LLC Cognizant Ennov
  Solutions Inc. Extedo GmbH Max Application Oracle
  Corporation Sarjen Systems Pvt Ltd Sparta Systems
  Inc. (Honeywell International Inc.)
  Tata Consultancy Services Limited
  United BioSource LLC Wipro Limited.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/pharmacovigilance-drug-
  safety-software-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us